Position in OVID
as of Mar 31, 2026
· filed May 12, 2026
Position Value
$1,632,651
+$191,950 QoQ
Shares Held
735,429
-16.8% QoQ
Ownership
0.377%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
19 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in OVID Over Time
Shares Held
Position Value (USD)
Derivatives in OVID
reported options exposure · as of Mar 31, 2026CallValue
$43,956
CallShares
19,800
PutValue
$0
PutShares
0
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Biotechnology
Healthcare · as of Jun 30, 2026JANE STREET GROUP, LLC holds $1,364,050,815 across 292 Biotechnology names.
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | BBIO |
BridgeBio Pharma, Inc.
|
2,934,193 | $218,538,693 | |
| 2 | MDGL |
Madrigal Pharmaceuticals, Inc.
|
191,541 | $102,847,939 | |
| 3 | AXSM |
Axsome Therapeutics, Inc.
|
403,995 | $98,885,855 | |
| 4 | TGTX |
Tg Therapeutics, Inc.
|
1,752,646 | $96,290,370 | |
| 5 | EXEL |
Exelixis, Inc.
|
1,402,438 | $76,306,651 | |
| 6 | QURE |
uniQure N.V.
|
1,610,483 | $74,178,846 | |
| 7 | HALO |
Halozyme Therapeutics, Inc.
|
694,684 | $54,372,915 | |
| 8 | TVTX |
Travere Therapeutics, Inc.
|
938,699 | $53,327,489 |
All Filings in OVID
Export CSV
20 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $1,632,651 | 735,429 | Shares | Defined | 2026-05-12 | |
| 2026-03-31 | $43,956 | 19,800 | Call | Defined | 2026-05-12 | |
| 2025-12-31 | $1,440,701 | 883,867 | Shares | Defined | 2026-02-12 | |
| 2025-09-30 | $309,939 | 238,415 | Shares | Defined | 2025-11-14 | |
| 2025-06-30 | $47,057 | 142,597 | Shares | Defined | 2025-08-14 | |
| 2024-12-31 | $13,335 | 14,278 | Shares | Defined | 2025-02-14 | |
| 2024-09-30 | $45,310 | 38,399 | Shares | Defined | 2024-11-15 | |
| 2024-06-30 | $75,814 | 98,590 | Shares | Defined | 2024-08-15 | |
| 2024-03-31 | $163,418 | 53,580 | Shares | Defined | 2024-05-16 | |
| 2023-12-31 | $163,901 | 50,901 | Shares | Defined | 2024-02-15 | |
| 2023-03-31 | $280,226 | 108,615 | Shares | Defined | 2023-05-16 | |
| 2022-12-31 | $109,959 | 59,118 | Shares | Defined | 2023-02-15 | |
| 2022-09-30 | $25,921 | 14,088 | Shares | Defined | 2022-11-15 | |
| 2022-06-30 | $24,540 | 11,414 | Shares | Defined | 2022-08-16 | |
| 2022-03-31 | $199,415 | 63,508 | Shares | Defined | 2022-05-17 | |
| 2021-06-30 | $300,964 | 76,973 | Shares | Defined | 2021-08-16 | |
| 2021-03-31 | $161,246 | 40,111 | Shares | Defined | 2021-05-18 | |
| 2020-09-30 | $201,399 | 35,087 | Shares | Defined | 2020-11-17 | |
| 2020-06-30 | $217,082 | 29,455 | Shares | Defined | 2020-08-17 | |
| 2020-03-31 | $159,313 | 53,461 | Shares | Defined | 2020-05-15 | |
| No filing history on record for this holder in this stock. | ||||||